Barinthus Biotherapeutics plc (FRA:2AB)
Germany · Delayed Price · Currency is EUR 0.4600
-0.0020 (-0.43%)
At close: Mar 27, 2026
Barinthus Biotherapeutics Market Cap
Barinthus Biotherapeutics has a market cap or net worth of €19.5 million as of March 27, 2026. Its market cap has decreased by -50.32% in one year.
Market Cap
19.50M
Enterprise Value
-31.79M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.46
Market Cap Chart
Since April 30, 2021, Barinthus Biotherapeutics's market cap has decreased from 399.28M to 19.50M, a decrease of -95.12%. That is a compound annual growth rate of -45.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 19.50M | -19.90% |
| Dec 31, 2025 | 24.35M | -48.13% |
| Dec 31, 2024 | 46.94M | -63.54% |
| Dec 29, 2023 | 128.74M | 56.98% |
| Dec 30, 2022 | 82.01M | -75.93% |
| Dec 31, 2021 | 340.74M | -14.66% |
| Apr 30, 2021 | 399.28M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biotest Aktiengesellschaft | 1.35B |
| Darwin AG | 92.40M |
| 2invest AG | 62.87M |
| Biomark Diagnostics | 37.83M |
| co.don AG | 360.77K |
| bioXXmed AG | 323.52K |
| Paion AG | 232.56K |
| MagForce AG | 137.58K |